Ferric citrate dosage forms
AssigneeKeryx Biopharmaceuticals, Inc.
InventorHenry Trong Le
Life of this patent
Estimating the term…
Abstract
The disclosure relates to ferric citrate tablets and dosage forms. In various embodiments, the tablets include ferric citrate formulations that meet certain dissolution, tableting and disintegration standards. In various aspects, the tablet formulations can include ferric citrate as the active ingredient and a binder. The formulations also can include a lubricant and/or a disintegrant (which, in some embodiments, can be the same as the binder).
Claims22
A tablet comprising granule particles, said granule particles comprising ferric citrate and a binder, wherein the mean surface area to mass ratio of said granule particles is equal to or greater than 1 m2 per gram
17-19. (canceled)
23-25. (canceled)
Dependencies are inferred from the claim text.